FERRETTI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 14.086
EU - Europa 4.456
AS - Asia 2.380
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AF - Africa 5
Totale 20.966
Nazione #
US - Stati Uniti d'America 14.068
IT - Italia 1.588
CN - Cina 1.308
UA - Ucraina 886
DE - Germania 648
TR - Turchia 641
GB - Regno Unito 327
SG - Singapore 294
SE - Svezia 276
PL - Polonia 242
FI - Finlandia 198
FR - Francia 98
ID - Indonesia 48
RU - Federazione Russa 41
ES - Italia 27
BE - Belgio 23
IN - India 19
CZ - Repubblica Ceca 17
HK - Hong Kong 17
CH - Svizzera 13
VN - Vietnam 13
NL - Olanda 12
CA - Canada 10
IR - Iran 10
RO - Romania 10
BR - Brasile 9
EU - Europa 9
MX - Messico 8
AU - Australia 7
EC - Ecuador 7
JP - Giappone 7
AT - Austria 6
RS - Serbia 6
SM - San Marino 6
DK - Danimarca 5
IE - Irlanda 5
PT - Portogallo 5
CO - Colombia 4
BD - Bangladesh 3
HU - Ungheria 3
KR - Corea 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
TH - Thailandia 3
ZA - Sudafrica 3
AL - Albania 2
EE - Estonia 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 20.966
Città #
Fairfield 2.120
Woodbridge 1.929
Jacksonville 1.118
Houston 1.063
Chandler 951
Ashburn 934
Seattle 840
Wilmington 724
Cambridge 718
Ann Arbor 697
Izmir 462
Nanjing 365
Princeton 284
Dearborn 237
Warsaw 237
Ferrara 204
Beijing 194
San Diego 170
Singapore 170
Bremen 162
Boardman 130
Milan 122
Nanchang 105
Rome 87
Hebei 83
Falls Church 75
New York 73
Shenyang 70
Tianjin 67
Shanghai 63
Changsha 52
Jiaxing 51
Jakarta 48
Redwood City 48
Mountain View 47
Kunming 45
Bologna 42
Orange 40
London 38
Norwalk 37
Jinan 36
Naples 35
Hefei 28
Zhengzhou 25
Guangzhou 22
Ningbo 22
San Mateo 22
Brussels 21
Turin 20
Helsinki 18
Chicago 17
Hong Kong 17
Los Angeles 16
Parma 15
Verona 15
Auburn Hills 14
Florence 14
Indiana 14
Lappeenranta 14
Redmond 14
Reggio Nell'emilia 14
Taizhou 13
Padova 12
Palermo 12
Des Moines 11
Lanzhou 11
Torino 11
Brno 10
Catania 10
Changchun 10
Modena 10
Dallas 9
Dong Ket 9
St Petersburg 9
Benevento 8
Foligno 8
Lucca 8
Tappahannock 8
Ardabil 7
Genova 7
Haikou 7
Imola 7
Kilburn 7
Munich 7
Paris 7
Pavia 7
Tokyo 7
Wuhan 7
Acquaviva 6
Guayaquil 6
Napoli 6
Philadelphia 6
Pisa 6
Amsterdam 5
Brescia 5
Centro 5
Chieti 5
Duncan 5
Fuzhou 5
Jesi 5
Totale 15.619
Nome #
Tumori Odontogeni misti: indagine sul significato delle correlazioni tra fibroma ameloblastico, fibro-odontoma ameloblastico e odontomi. 459
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 344
Survival of cancer patients in Europe: the EUROCARE study 229
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 227
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 218
I tumori in Emilia-Romagna 211
I tumori in Italia, rapporto 2007: sopravvivenza. 206
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 144
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 140
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 134
Completeness and timeliness: Cancer registries could/should improve their performance 127
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 127
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 125
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 124
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 124
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 121
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 121
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 120
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 119
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 116
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 113
International incidence of childhood cancer, 2001-10: a population-based registry study 113
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 112
Cancer prevalence estimates in Europe at the beginning of 2000 111
Impatto delle cure palliative sull'assistenza dei pazienti oncologici in fase terminale in provincia di Ferrara nel 2002. 109
Early (short-interval) rescreen in mammography screening 109
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 108
Estimates of cancer burden in Emilia-Romagna 108
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 108
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 108
Regional inequalities in cancer care persist in Italy and can influence survival. 107
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 106
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 106
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 106
Modulation of biomarkers in minimal breast carcinoma 105
Incidence, survival and prevalence of myeloid malignancies in Europe 105
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. 105
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 105
Cancer incidence and mortality trends from 2003 to 2014 in Italy 105
null 104
Application of quantitative analysis to biologic profile evaluation in breast cancer 104
Epidemiology of rare cancers and inequalities in oncologic outcomes 104
Breast screening: axillary lymph node status of interval cancers by interval year 103
Survival of European patients with central nervous system tumors 103
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 103
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 103
The burden of HPV-related diseases in Italy, 2001-12 102
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 102
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 101
Comparative cancer survival information in Europe 101
Estimates of cancer burden in Italy 100
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 100
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 100
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis 99
Treatment challenges in and outside a network setting: Soft tissue sarcomas 99
Estimated and observed cancer incidence in Italy: a validation study. 98
null 98
Rare cancers are not so rare: the rare cancer burden in Europe 97
Rare cancers of the head and neck area in Europe 97
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 97
Cancer incidence and mortality in the province of Ferrara 1989-1990 97
Changes in cervical cancer incidence following the introduction of organized screening in Italy 97
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 97
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 97
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 96
Incidence and survival of rare urogenital cancers in Europe 96
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 96
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 96
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 96
Registro Tumori della provincia di Ferrara 95
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 95
null 94
null 94
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 94
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 94
null 93
null 93
null 93
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 93
Rare thoracic cancers, including peritoneum mesothelioma 93
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 93
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study 92
null 92
National estimates of cancer patients survival in italy: A model-based method 91
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary 91
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 91
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 91
Epidemiology of glial and non-glial brain tumours in Europe 91
null 90
null 90
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 90
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project 89
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 89
Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study 89
Treatment challenges in and outside a network setting: Head and neck cancers 89
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 89
Invasive extramammary Paget's disease and the risk for secondary tumours in Europe 88
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 88
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: Comparison between European population-based data (EUROCARE-5) 88
Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project 87
Totale 11.397
Categoria #
all - tutte 87.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.876
Totale 90.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.119 841 178 190 729 387 709 549 521 423 340 148 104
2020/20213.526 232 268 274 407 265 314 155 416 179 410 367 239
2021/20222.556 87 296 205 167 129 144 136 195 109 204 188 696
2022/20232.594 313 127 52 267 490 382 61 256 332 34 170 110
2023/20241.428 171 169 60 75 99 125 62 74 44 67 90 392
2024/2025128 128 0 0 0 0 0 0 0 0 0 0 0
Totale 21.461